Transforming Academic Drug Discovery

Abstract

A drug accelerator that partners the creative power of academic scientists with drug discovery professionals to consistently advance groundbreaking biological discoveries would be transformational. One such model, the Tri-Institutional Therapeutics Discovery Institute, evolved a series of best practices for identifying, selecting, executing, and completing academic-initiated drug discovery projects, is described.

Keywords: drug delivery; drug design; drug discovery; inhibitors; medicinal chemistry.